GlassScriptPhysician profile
Katherine Howarth
NPI 1891545513
$692.76
in general payments reported to CMS, 2019-2025
13 companies · $301 in 2025
The $301 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $392 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $693.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $692.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $254.31 | 2024-2025 | |
| Madrigal Pharmaceuticals | $111.92 | 2024-2025 | Rezdiffra, Resmetirom |
| Janssen Biotech, INC. | $56.12 | 2025 | Tremfya |
| Takeda Pharmaceuticals U.S.A., INC. | $50.10 | 2024-2025 | Entyvio |
| Genzyme Corporation | $47.10 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $42.53 | 2024 | Dupixent |
| Ipsen Biopharmaceuticals, INC | $26.03 | 2025 | Iqirvo |
| Merck Sharp & Dohme LLC | $24.63 | 2024 | Dificid |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.92 | 2025 | Xifaxan |
| Philips North America LLC | $18.51 | 2025 | Vest Therapy Und |
| Organon LLC | $14.54 | 2025 | Hadlima, Renflexis |
| Lilly USA, LLC | $13.59 | 2024 | Omvoh |
| Phathom Pharmaceuticals, INC. | $12.46 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Howarth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.